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Soil-transmitted helminths (STHs), most notably, hookworms, whipworms, and Ascaris, 
are nematodes that infect more than 1.5 billion of the poorest people and are amongst 
the leading causes of morbidity worldwide. Only two classes of de-worming drugs 
(anthelmintics) are available for treatment, and only one is commonly used in mass drug 
administrations. New anthelmintics are urgently needed to overcome emerging 
resistance and to produce higher cure rates.  Crystal (Cry) proteins, in particular Cry5B, 
made by Bacillus thuringiensis (Bt) are promising new candidates.  Cry5B has excellent 
anthelmintic properties against many free-living and parasitic nematodes, including in 
vivo efficacy against multiple STH infections in rodents (Heligomasmidoes polygyrus and 
Ancylostoma ceylanicum) and in pigs (Ascaris suum).  
 
An enormous challenge for STHs, very different from most diseases worked on in the 
developing world, is the requirement that therapies be very cheap (the people infected 
are very poor and current drugs costs pennies a dose), massively scalable (over 4 billion 
people are at risk from infection), and have a long shelf life in harsh environments, that 
have high temperature and humidity and no cold chain. 
 
We will update our progress in several key areas.  We will present new data on the in 
vivo activity of Cry5B against a major human parasite in humans.  We will also present 
data on the whether or not the immune system is required for Cry5B action in vivo.  We 
will also present on our development efforts to produce a deployable version of Cry5B 
that is cheap, safe, scalable, and stable.  These efforts are currently focused on bacterial 
engineering, expression, and formulation.  
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